Efficacy and safety of daclatasvir and asunaprevir combination therapy in chronic hemodialysis patients with chronic hepatitis C

被引：0
|
作者：
Goki Suda
Mineo Kudo
Atsushi Nagasaka
Ken Furuya
Yoshiya Yamamoto
Tomoe Kobayashi
Keisuke Shinada
Miki Tateyama
Jun Konno
Yoko Tsukuda
Kazushi Yamasaki
Megumi Kimura
Machiko Umemura
Takaaki Izumi
Seiji Tsunematsu
Fumiyuki Sato
Katsumi Terashita
Masato Nakai
Hiromasa Horimoto
Takuya Sho
Mitsuteru Natsuizaka
Kenichi Morikawa
Koji Ogawa
Naoya Sakamoto
机构：
[1] Graduate School of Medicine,Department of Gastroenterology and Hepatology
[2] Hokkaido University,undefined
[3] Sapporo Hokuyu Hospital,undefined
[4] Sapporo City General Hospital,undefined
[5] JCHO Hokkaido Hospital,undefined
[6] Hakodate City Hospital,undefined
[7] Tomakomai City Hospital,undefined
[8] Keiwakai Ebetsu Hospital,undefined
[9] Tomakomai Nissho Hospital,undefined
[10] Hakodate Central General Hospital,undefined
来源：
Journal of Gastroenterology | 2016年 / 51卷
关键词：
HCV; Hemodialysis; Daclatasvir; Asunaprevir;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：733 / 740
页数：7
相关论文
共 50 条
  • [21] Daclatasvir and asunaprevir combination therapy for patients with chronic hepatitis C virus genotype 1b infection in real world
    Oh, Jae Young
    Kim, Byung Seok
    Lee, Chang Hyeong
    Song, Jeong Eun
    Lee, Heon Ju
    Park, Jung Gil
    Hwang, Jae Seok
    Chung, Woo Jin
    Jang, Byoung Kuk
    Kweon, Young Oh
    Tak, Won Young
    Park, Soo Young
    Jang, Se Young
    Suh, Jeong Ill
    Kwak, Sang Gyu
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2019, 34 (04): : 794 - 801
  • [22] EFFICACY OF DACLATASVIR/ASUNAPREVIR FOR PATIENTS WITH CHRONIC HEPATITIS C 1B COMPLICATED WITH RENAL INSUFFICIENCY
    Atsukawa, M.
    Shimada, N.
    Tsubota, A.
    Abe, H.
    Okubo, T.
    Nakagawa, A.
    Arai, T.
    Itokawa, N.
    Kondo, C.
    Tanaka, Y.
    Aizawa, Y.
    Iwakiri, K.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S795 - S795
  • [23] Severe Hepatotoxicity Associated With Asunaprevir and Daclatasvir in Chronic Hepatitis C
    Shibata, Soichiro
    Umemura, Takeji
    Komatsu, Michiharu
    Tanaka, Eiji
    HEPATOLOGY, 2016, 63 (06) : 2063 - 2064
  • [24] Efficacy of daclatasvir plus asunaprevir in patients with hepatitis C virus infection undergoing and not undergoing hemodialysis
    Fujii, Hideki
    Kimura, Hiroyuki
    Kurosaki, Masayuki
    Hasebe, Chitomi
    Akahane, Takehiro
    Yagisawa, Hitoshi
    Kato, Keizo
    Yoshida, Hideo
    Itakura, Jun
    Sakita, Shinya
    Satou, Takashi
    Okada, Kazuhiko
    Kusakabe, Atsunori
    Kojima, Yuji
    Kondo, Masahiko
    Morita, Atsuhiro
    Nasu, Akihiro
    Tamada, Takashi
    Okushin, Hiroaki
    Kobashi, Haruhiko
    Tsuji, Keiji
    Joko, Kouji
    Ogawa, Chikara
    Uchida, Yasushi
    Mitsuda, Akeri
    Sohda, Tetsuro
    Ide, Yasushi
    Izumi, Namiki
    HEPATOLOGY RESEARCH, 2018, 48 (09) : 746 - 756
  • [25] COST-EFFECTIVENESS ANALYSIS OF DACLATASVIR IN COMBINATION WITH ASUNAPREVIR (DUAL) FOR THE TREATMENT OF CHRONIC HEPATITIS C PATIENTS IN CHINA
    Cheng, W.
    Chen, W.
    VALUE IN HEALTH, 2018, 21 : S154 - S154
  • [26] Daclatasvir and asunaprevir for genotype 1b chronic hepatitis C patients with chronic kidney disease
    Kondo, Chisa
    Atsukawa, Masanori
    Tsubota, Akihito
    Shimada, Noritomo
    Abe, Hiroshi
    Asano, Toru
    Yoshizawa, Kai
    Okubo, Tomomi
    Chuganji, Yoshimichi
    Aizawa, Yoshio
    Iio, Etsuko
    Tanaka, Yasuhito
    Iwakiri, Katsuhiko
    HEPATOLOGY RESEARCH, 2017, 47 (11) : 1165 - 1173
  • [27] Efficacy and safety of dual therapy with daclatasvir and asunaprevir in elderly patients
    Kazuo Tarao
    Katsuaki Tanaka
    Akito Nozaki
    Akira Sato
    Toshiya Ishii
    Hirokazu Komatsu
    Takaaki Ikeda
    Tatsuji Komatsu
    Shozo Matsushima
    Kenji Oshige
    World Journal of Hepatology, 2017, (11) : 544 - 550
  • [28] A randomized trial of daclatasvir in combination with asunaprevir and beclabuvir in patients with chronic hepatitis C virus genotype 4 infection
    Hassanein, Tarek
    Sims, Karen D.
    Bennett, Michael
    Gitlin, Norman
    Lawitz, Eric
    Nguyen, Tuan
    Webster, Lynn
    Younossi, Zobair
    Schwartz, Howard
    Thuluvath, Paul J.
    Zhou, Helen
    Rege, Bhaskar
    McPhee, Fiona
    Zhou, Nannan
    Wind-Rotolo, Megan
    Chung, Ellen
    Griffies, Amber
    Grasela, Dennis M.
    Gardiner, David F.
    JOURNAL OF HEPATOLOGY, 2015, 62 (05) : 1204 - 1206
  • [29] ASSESSING THE ECONOMIC IMPACT OF THE INTRODUCTION OF DACLATASVIR IN COMBINATION WITH ASUNAPREVIR FOR THE TREATMENT OF CHRONIC HEPATITIS C IN CHINA
    Ward, T.
    Gordon, J.
    Wygant, G.
    Yan, J.
    Wang, F.
    McEwan, P.
    VALUE IN HEALTH, 2017, 20 (09) : A782 - A782
  • [30] Single nucleotide polymorphisms associated with elevated alanine aminotransferase in patients receiving asunaprevir plus daclatasvir combination therapy for chronic hepatitis C
    Kato, Keizo
    Shimada, Noritomo
    Atsukawa, Masanori
    Abe, Hiroshi
    Itokawa, Norio
    Matsumoto, Yoshihiro
    Agata, Rie
    Tsubota, Akihito
    PLOS ONE, 2019, 14 (07):
12345